Massachusetts recently enacted a law that might have major impact on investors in the healthcare industry, notable private equity. House Bill 5159 imposes a new rule on those who invest in healthcare companies in the state, requiring disclosure of False Claims Act violations that the companies they invest in may be liable for, or else […]

In January 2025, Hino Motors Ltd., a subsidiary of Toyota Motor Corporation, agreed to a comprehensive settlement exceeding $1.6 billion with U.S. authorities to resolve allegations of emissions fraud. This resolution addresses both criminal charges and civil claims related to the company's misconduct in falsifying engine emission and fuel consumption data. Of interest to whistleblowers […]

The Department of Justice (DOJ) last week reported nearly $3 billion in recoveries under the False Claims Act (FCA) for fiscal year 2024. These successful FCA cases targeted fraud in healthcare, defense contracting, pandemic relief, and cybersecurity, among other areas. A significant portion, $1.67 billion, came from healthcare fraud cases, including improper billing practices and […]

Last week, the Department of Justice (DOJ) announced a $15.875 million settlement with Booz Allen Hamilton over alleged False Claims Act (FCA) violations involving a scheme to rig Department of Defense (DoD) bids using insider information. The alleged fraud centered on a Booz Allen subsidiary, Booz Allen Hamilton Engineering Services (BES), which supplied military training […]

Right before the holidays, we proudly announced a settlement of up to $100 million with Independent Health, a Western New York-based insurer, and one of its former executives. Several news outlets have since highlighted the settlement and the importance of whistleblowers in the healthcare industry, which is unfortunately a hotbed of fraud. In its case […]